Historique de carrière de W. Wigley
Anciens postes connus de W. Wigley
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REATA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - | 26/09/2023 |
| Corporate Officer/Principal | 01/01/2002 | - | |
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | - | - |
Formation de W. Wigley
| Texas Tech University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
